Orgenesis Inc. Elects New Directors to Board
Ticker: ORGS · Form: 8-K · Filed: Oct 23, 2024 · CIK: 1460602
| Field | Detail |
|---|---|
| Company | Orgenesis INC. (ORGS) |
| Form Type | 8-K |
| Filed Date | Oct 23, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-of-directors, governance
TL;DR
Orgenesis adds two new Glick directors to the board, effective immediately.
AI Summary
Orgenesis Inc. announced on October 23, 2024, a change in its board of directors. Specifically, the company elected two new directors, Dr. David J. Glick and Mr. David M. Glick, to its Board of Directors, effective immediately. This move is part of the company's ongoing efforts to strengthen its governance and strategic direction.
Why It Matters
The addition of new directors can signal a shift in strategic focus or governance for Orgenesis Inc., potentially impacting its future business operations and shareholder value.
Risk Assessment
Risk Level: low — The filing reports routine board changes, which typically carry low immediate risk.
Key Players & Entities
- Orgenesis Inc. (company) — Registrant
- Dr. David J. Glick (person) — Newly elected director
- Mr. David M. Glick (person) — Newly elected director
- October 23, 2024 (date) — Effective date of director election
FAQ
Who were the newly elected directors for Orgenesis Inc.?
Dr. David J. Glick and Mr. David M. Glick were elected as new directors.
When were the new directors elected?
The election of the new directors was effective immediately as of October 23, 2024.
What is the primary business of Orgenesis Inc.?
Orgenesis Inc. is in the Pharmaceutical Preparations industry (SIC code 2834).
In which state is Orgenesis Inc. incorporated?
Orgenesis Inc. is incorporated in Nevada (NV).
What is the principal executive office address for Orgenesis Inc.?
The principal executive offices are located at 20271 Goldenrod Lane, Germantown, MD 20876.
Filing Stats: 595 words · 2 min read · ~2 pages · Grade level 12.6 · Accepted 2024-10-23 17:00:19
Filing Documents
- form8-k.htm (8-K) — 32KB
- 0001493152-24-042252.txt ( ) — 200KB
- orgs-20241023.xsd (EX-101.SCH) — 3KB
- orgs-20241023_lab.xml (EX-101.LAB) — 33KB
- orgs-20241023_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGENESIS INC. Date: October 23, 2024 By: /s/ Victor Miller Victor Miller Chief Financial Officer, Treasurer and Secretary